WeSearch

STAT+: Talawar bets bispecific approach can shake up eczema market

Meghana Keshavan· ·1 min read · 0 reactions · 0 comments · 6 views
STAT+: Talawar bets bispecific approach can shake up eczema market

Moderna still bullish on mRNA, Ipsen's acquisition of Kartos, and more biotech news from The Readout

Original article
STAT · Meghana Keshavan
Read full at STAT →
Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from STAT

Opinion: Supreme Court ruling on Roundup points to a confusing difference between the law and science
STAT·11
Supreme Court rules in weedkiller cancer case
STAT·22
STAT+: Proposed CDC science office could tighten political control at agency
STAT·16
STAT+: Next-gen CRISPR tools improve editing accuracy in embryos, but also stoke ethical concerns
STAT·20
STAT+: Democrats press White House on who got special access to Eli Lilly’s new obesity drug
STAT·10
STAT+: FDA’s breakthrough pipeline fills up with generative AI devices
STAT·19